Tempest Therapeutics (TPST) EPS (Basic) (2012 - 2026)
Tempest Therapeutics (TPST) posted EPS (Basic) of -$0.98 for Q4 2025, up 69.69% sequentially from -$3.24 in Q3 2025, and up 85.1% YoY from -$0.53 in Q4 2024.
Tempest Therapeutics (TPST) EPS (Basic) (2012 - 2026) Analysis & Trends
Tempest Therapeutics has reported EPS (Basic) for 14 years, with the latest figure at -$0.98 in Q4 2025.
- Quarterly EPS (Basic) rose 85.1% year-over-year to -$0.98 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$9.67 (up 52.1% YoY) and the FY2025 annual result came in at -$6.94, up 93.2% from the prior year.
- EPS (Basic) grew to -$0.98 in Q4 2025 per TPST's latest filing, from -$3.24 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.98 in Q4 2025 and troughed at -$99.15 in Q2 2021.
- A 5-year average of -$14.23 and a median of -$6.9 in 2023 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2021 and 2024: EPS (Basic) soared 96.33% in 2021, then tumbled 360.32% in 2024.
- Over 5 years, EPS (Basic) stood at -$13.0 in 2021, then gained by 18.87% to -$10.54 in 2022, then soared by 86.41% to -$1.43 in 2023, then sank by 360.32% to -$6.6 in 2024, then jumped by 85.1% to -$0.98 in 2025.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.98, -$3.24, and -$2.78 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Tempest Therapeutics | 4.32 Mn | 3.52 Mn | - | -1.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.27 |
| Dec 31, 2025 | -0.98 |
| Sep 30, 2025 | -3.24 |
| Jun 30, 2025 | -2.78 |
| Mar 31, 2025 | -3.23 |
| Dec 31, 2024 | -6.60 |
| Sep 30, 2024 | -5.48 |
| Jun 30, 2024 | -5.74 |
| Mar 31, 2024 | -4.88 |
| Dec 31, 2023 | -1.43 |
| Sep 30, 2023 | -6.41 |
| Jun 30, 2023 | -7.21 |
| Mar 31, 2023 | -7.49 |
| Dec 31, 2022 | -10.54 |
| Sep 30, 2022 | -8.63 |
| Jun 30, 2022 | -10.37 |
| Mar 31, 2022 | -16.05 |
| Dec 31, 2021 | -13.00 |
| Sep 30, 2021 | -16.44 |
| Jun 30, 2021 | -99.15 |